News
CLXT
0.3750
+3.56%
0.0129
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 03/08 17:31
Calyxt GAAP EPS of -$0.06, revenue of $0.04M
Seeking Alpha · 03/06 22:05
Calyxt GAAP EPS of -$0.06
Seeking Alpha · 03/02 21:41
BRIEF-Calyxt Reports Q4 2022 Financial Results And Provides Corporate Update
Reuters · 03/02 21:40
Calyxt Q4 EPS $(0.06) Beats $(0.11) Estimate
Benzinga · 03/02 21:27
-- Earnings Flash (CLXT) CALYXT Reports Q4 Revenue $42,000
-- Earnings Flash (CLXT) CALYXT Reports Q4 Revenue $42,000
MT Newswires · 03/02 16:12
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 02/13 19:12
Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/13 12:43
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 02/10 21:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 01/31 13:06
Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/20 12:55
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 01/19 18:33
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 01/18 18:25
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 01/18 13:06
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/18 12:50
Nasdaq Edges Higher; Neovasc Shares Jump
Benzinga · 01/17 19:50
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 01/17 18:21
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 01/17 17:31
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Benzinga · 01/17 17:07
More
Webull provides a variety of real-time CLXT stock news. You can receive the latest news about Calyxt through multiple platforms. This information may help you make smarter investment decisions.
About CLXT
Calyxt, Inc. is a plant-based biotechnology platform company. The Company is focused on research and development, including gene editing, plant breeding, and trait development. It specializes in engineering plant metabolisms. The Company operates through the development and commercialization of products derived from plant cells. Its platform provides plant-based synthetic biology solutions to customers across multiple industries. The Company has engineered plant metabolism into products including soybeans with improved fatty-acid profiles and alfalfa able to be better digested by livestock. Its product pipeline includes hemp, winter oats, and high saturated fat soybeans. Hemp serves a range of varieties of materials science needs, including strengthening plastics and reducing petroleum-based content. The Company's customers include seed companies, biotechnology companies, germplasm providers, agricultural processors, and others in the crop’s supply chain and growers.